These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The antipsychotropic drug Duloxetine rescues PAX6 haploinsufficiency of mutant limbal stem cells through inhibition of the MEK/ERK signaling pathway. Dorot O; Roux LN; Zennaro L; Oved K; Bremond-Gignac D; Pichinuk E; Aberdam D Ocul Surf; 2022 Jan; 23():140-142. PubMed ID: 34890804 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of Pax6 results in microphthalmia, retinal dysplasia and defective retinal ganglion cell axon guidance. Manuel M; Pratt T; Liu M; Jeffery G; Price DJ BMC Dev Biol; 2008 May; 8():59. PubMed ID: 18507827 [TBL] [Abstract][Full Text] [Related]
8. Developmental and cellular factors underlying corneal epithelial dysgenesis in the Pax6+/- mouse model of aniridia. Ramaesh T; Ramaesh K; Martin Collinson J; Chanas SA; Dhillon B; West JD Exp Eye Res; 2005 Aug; 81(2):224-35. PubMed ID: 16080917 [TBL] [Abstract][Full Text] [Related]
9. Xenopus pax6 mutants affect eye development and other organ systems, and have phenotypic similarities to human aniridia patients. Nakayama T; Fisher M; Nakajima K; Odeleye AO; Zimmerman KB; Fish MB; Yaoita Y; Chojnowski JL; Lauderdale JD; Netland PA; Grainger RM Dev Biol; 2015 Dec; 408(2):328-44. PubMed ID: 25724657 [TBL] [Abstract][Full Text] [Related]
10. Cloning and characterization of canine PAX6 and evaluation as a candidate gene in a canine model of aniridia. Hunter LS; Sidjanin DJ; Hijar MV; Johnson JL; Kirkness E; Acland GM; Aguirre GD Mol Vis; 2007 Mar; 13():431-42. PubMed ID: 17417604 [TBL] [Abstract][Full Text] [Related]
11. Non-invasive anterior segment and posterior segment optical coherence tomography and phenotypic characterization of aniridia. Gregory-Evans K; Cheong-Leen R; George SM; Xie J; Moosajee M; Colapinto P; Gregory-Evans CY Can J Ophthalmol; 2011 Aug; 46(4):337-44. PubMed ID: 21816254 [TBL] [Abstract][Full Text] [Related]
12. Identification of novel mutant PAX6 alleles in Indian cases of familial aniridia. Neethirajan G; Nallathambi J; Krishnadas SR; Vijayalakshmi P; Shashikanth S; Collinson JM; Sundaresan P BMC Ophthalmol; 2006 Jun; 6():28. PubMed ID: 16803629 [TBL] [Abstract][Full Text] [Related]
13. A [c.566-2A>G] heterozygous mutation in the PAX6 gene causes aniridia with mild visual impairment. Beby F; Dieterich K; Calvas P Eye (Lond); 2011 May; 25(5):657-8. PubMed ID: 21274015 [No Abstract] [Full Text] [Related]
14. Molecular analysis of the PAX6 gene for congenital aniridia in the Korean population: identification of four novel mutations. Park SH; Kim MS; Chae H; Kim Y; Kim M Mol Vis; 2012; 18():488-94. PubMed ID: 22393275 [TBL] [Abstract][Full Text] [Related]
15. Histopathological characterisation of effects of the mouse Pax6(Leca4) missense mutation on eye development. Ramaesh T; Williams SE; Paul C; Ramaesh K; Dhillon B; West JD Exp Eye Res; 2009 Aug; 89(2):263-73. PubMed ID: 19345209 [TBL] [Abstract][Full Text] [Related]
16. Aniridia with a heterozygous PAX6 mutation in which the pituitary function was partially impaired. Shimo N; Yasuda T; Kitamura T; Matsushita K; Osawa S; Yamamoto Y; Kozawa J; Otsuki M; Funahashi T; Imagawa A; Kaneto H; Nishida K; Shimomura I Intern Med; 2014; 53(1):39-42. PubMed ID: 24390526 [TBL] [Abstract][Full Text] [Related]
17. Mutation analysis of PAX6 in inherited and sporadic aniridia from northeastern China. Kang Y; Lin Y; Li X; Wu Q; Huang L; Li Q; Hu Q Mol Vis; 2012; 18():1750-4. PubMed ID: 22815628 [TBL] [Abstract][Full Text] [Related]
18. Aniridia: a comparative overview. Schanilec P; Biernacki R Am Orthopt J; 2014; 64():98-104. PubMed ID: 25313118 [TBL] [Abstract][Full Text] [Related]
19. PAX6 3' deletion in a family with aniridia. Wawrocka A; Budny B; Debicki S; Jamsheer A; Sowinska A; Krawczynski MR Ophthalmic Genet; 2012 Mar; 33(1):44-8. PubMed ID: 21985185 [TBL] [Abstract][Full Text] [Related]